Background: Studies of depression and anxiety in multiple sclerosis (MS) patients have
reported higher rates in MS patients than the general population. Objective: To estimate the …

Multiple sclerosis (MS) is a neuroinflammatory condition characterized by chronic
dysregulation of immune responses leading to repeated episodes of inflammation in the …

Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue,
and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives …

Introduction: Multiple Sclerosis (MS) is a neurological disease, which leads to an increased
risk for development of emotional and mental disorders and increased suicide risk. Many …

Objective: To report the occurrence, type, causes, and management of psychiatric
manifestations in multiple sclerosis (MS). Method: Review of recent, relevant literature …

Background There is limited knowledge regarding how depressive symptoms and a cluster
of specific mood symptoms in people with multiple sclerosis (MS) vary over time and how …

Aims: Multiple sclerosis (MS) is the most common cause of neurological disability in young
adults and is frequently accompanied by symptoms of depression and anxiety. The aim of …

Background Multiple sclerosis (MS) is a demyelinating disease that can damage neurons in
the brain and spinal cord and is associated with several psychiatric disorders. However, few …

Abstract Background: Multiple Sclerosis is one of the leading autoimmune disorders causing
disability among young adults. Various types of mood, affect, and behaviour disorders along …

Multiple sclerosis (MS) is an autoimmune, inflammatory, neurodegenerative disease of the
central nervous system, characterised by demyelinisation and axonal damage. The …